Global Healthcare Reach Marken operates in over 220 countries and territories with a robust air, sea and ground network, presenting opportunities to upsell integrated global logistics for complex clinical trials, patient-focused delivery, and regulated distribution services.

Advanced Therapy Focus With an dedicated advanced therapies division, leadership in cell and gene operations, and launches like Solo platform, there is a clear cross-sell path for specialized cold-chain, regulatory management, and clinical trial logistics for high-value therapies.

Integrated Packaging The ready-now packaging catalog and new Marken InfiniDI reusable dry ice solution position Marken to offer sustainable, cost-efficient temperature-controlled packaging as a service to biotech and pharma clients expanding cold-chain needs.

Strategic Acquisitions Past acquisitions such as Bomi Group and Cedra Express indicate Marken’s growth through integrations; sales opportunities exist in bundling cross-border courier, storage, and distribution capabilities with existing UPS Healthcare networks.

Digital and Regulatory Edge Proprietary tools like Solo and ongoing tech stack adoption suggest a value proposition around end-to-end regulatory, inventory, and supply chain orchestration for clinical trials and personalized medicine, appealing to sponsors seeking visibility and compliance.